Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs7499903 | chr16:8763412 | G/A | 0 | 178 | 25.47 | 23.53 | 3.17 | KM Plot |
PCPG | rs7500626 | chr16:1734671 | G/A | 0 | 173 | 25.53 | 18.2 | 2.93 | KM Plot |
PCPG | rs75110337 | chr16:89962635 | C/A | 0.000157 | 174 | 25.87 | 22.63 | 36.37 | KM Plot |
PCPG | rs75116202 | chr7:105160059 | C/T | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs75137110 | chr8:121463924 | A/G | 4.57E-6 | 177 | 27.2 | 25 | 19.87 | KM Plot |
PCPG | rs75163917 | chr16:90081032 | T/G | 1.12E-8 | 173 | 25.77 | 20.37 | 6.62 | KM Plot |
PCPG | rs7516737 | chr1:212786163 | T/C | 0.000128 | 172 | 25.67 | 24.23 | 14.6 | KM Plot |
PCPG | rs7517921 | chr1:243856420 | T/C | 0.000131 | 175 | 24.53 | 27.33 | 19.87 | KM Plot |
PCPG | rs7517995 | chr1:56347686 | C/T | 1.94E-5 | 173 | 25.87 | 26.57 | 13.27 | KM Plot |
PCPG | rs75187592 | chr2:118548498 | G/A | 1.62E-5 | 178 | 25.17 | 25.97 | 11.65 | KM Plot |
PCPG | rs75197080 | chr16:71752576 | C/G | 9.25E-6 | 175 | 23.83 | 32.03 | 14.5 | KM Plot |
PCPG | rs75217841 | chr14:74545918 | G/A | 0.000221 | 176 | 25.28 | 27.43 | 10.43 | KM Plot |
PCPG | rs75218563 | chr16:71815702 | T/C | 1.16E-5 | 174 | 24.7 | 29.43 | 14.5 | KM Plot |
PCPG | rs75265219 | chr12:56640341 | G/A | 9.68E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |
PCPG | rs75269469 | chr10:29847532 | T/A | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |